Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Sarcopenia might function as an indicator for frailty, and as such as a risk factor for the development of postoperative complications. The aim of this study was to meta‐analyse the relation between preoperative sarcopenia and the development of severe postoperative complications in patients undergoing oncological surgery.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>PubMed and Embase databases were systematically searched from inception until May 2018. Included were studies reporting on the incidence of severe postoperative complications and radiologically determined preoperative sarcopenia. Studies reporting the skeletal muscle as a continuous variable only were excluded. Data were extracted independently by two reviewers. Random effect meta‐analyses were applied to estimate the pooled odds ratio (OR) with 95% confidence intervals (95% CI) for severe postoperative complications, defined as Clavien‐Dindo grade ≥3, including 30‐day mortality. Heterogeneity was evaluated with <i>I</i><sup>2</sup> testing. Analyses were performed overall and stratified by measurement method, tumour location and publication date. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>A total of 1924 citations were identified, and 53 studies (14 295 patients) were included in the meta‐analysis. When measuring the total skeletal muscle area, 43% of the patients were sarcopenic, versus 33% when measuring the psoas area. Severe postoperative complications were present in 20%, and 30‐day mortality was 3%. Preoperative sarcopenia was associated with an increased risk of severe postoperative complications (OR<sub>pooled</sub>: 1.44, 95% CI: 1.24–16.8, <i>P</i><0.001, <i>I</i><sup>2</sup>=55%) and 30‐day mortality (OR<sub>pooled</sub>: 2.15, 95% CI: 1.46–3.17, <i>P</i><0.001, <i>I</i><sup>2</sup>=14%). A low psoas mass was a stronger predictor for severe postoperative complications compared with a low total skeletal muscle mass (OR<sub>pooled</sub>: 2.06, 95% CI: 1.37–3.09, OR<sub>pooled</sub>: 1.32, 95% CI: 1.14–1.53, respectively) and 30‐day mortality [OR<sub>pooled</sub>: 6.17 (95% CI: 2.71–14.08, OR<sub>pooled</sub>: 1.80 (95% CI: 1.24–2.62), respectively]. The effect was independent of tumour location and publication date. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>The presence of low psoas mass prior to surgery, as an indicator for sarcopenia, is a common phenomenon and is a strong predictor for the development of postoperative complications. The presence of low total skeletal muscle mass, which is even more frequent, is a less informative predictor for postoperative complications and 30‐day mortality. The low heterogeneity indicates that the finding is consistent over studies. Nevertheless, the value of sarcopenia relative to other assessments such as frailty screening is not clear. Research is needed in order to determine the place of sarcopenia in future preoperative risk stratification.</p></section>

Sarcopenia defined by the psoas muscle mass or quality is associated with poor survival in patients with aortic aneurysm undergoing surgery: A meta-analysis

Prognostic Value of Sarcopenia in Patients with Rectal Cancer: A Meta-Analysis.

Preoperative Computed Tomography-Assessed Skeletal Muscle Index is a Novel Prognostic Factor in Patients with Hepatocellular Carcinoma Following Hepatectomy: a Meta-Analysis.

Low muscle mass determined by psoas muscle area does not correlate with dual-energy x-ray absorptiometry or total lumbar muscle mass scores: A prospective cohort study of patients undergoing vascular surgery

Impact of Psoas Muscle Area Index on Short- and Mid-Term Mortality in Patients Undergoing Valve Surgery for Infective Endocarditis: A Retrospective Analysis

The Impact of Sarcopenia in the Long-Term Survival of Patients following Complex Endovascular Aortic Surgery for Thoracoabdominal Aortic Aneurysms

Association of sarcopenia, as defined based on the skeletal muscle index, with mortality and morbidity after cardiac surgery: a retrospective cohort study

Psoas Muscle Index Predicts 90 Day Mortality In Patients Undergoing Left Ventricular Assist Device Implantation

Sarcopenia Predicts Adverse Outcomes in an Elderly Population with Coronary Artery Disease: a Systematic Review and Meta-Analysis

Low skeletal muscle mass and postoperative morbidity in surgical oncology: a systematic review and meta‐analysis

Decreased Psoas Muscle Area is a Prognosticator for 90-Day and 1-Year Survival in Patients Undergoing Surgical Treatment for Spinal Metastasis

Impact of Muscle Mass on Survival in Patients with Sepsis: A Systematic Review and Meta-Analysis

Pre-operative Assessment of Muscle Mass to Predict Surgical Complications and Prognosis in Patients With Endometrial Cancer

Sarcopenia Is Associated With Increased Mortality in Patients With Necrotizing Soft Tissue Infections

Psoas muscle area is an independent survival prognosticator in patients undergoing surgery for long‐bone metastases

Total Psoas Area Index is Valuable to Assess Sarcopenia, Sarcopenic Overweight/Obesity and Predict Outcomes in Patients Undergoing Open Pancreatoduodenectomy

Sarcopenia as an important determinant for adverse outcomes in patients with pyogenic liver abscess

Prognostic Value of Sarcopenia in Older Adults with Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

Magnetic Resonance Imaging - Derived Psoas Muscle Area and Survival in Patients Treated Invasively for Peripheral Arterial Disease

Clinical impact of Sarcopenia on long-term mortality in patients undergoing coronary bypass grafting

Sarcopenia Predicts Overall Survival in Patients with Lung, Breast, Prostate, or Myeloma Spine Metastases Undergoing Stereotactic Body Radiation Therapy (SBRT), Independent of Histology